(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDICUBE RED CENTELLA BALM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDICUBE RED CENTELLA BALM

ST13

US500000090858996

Class

3

Filing

90858996

Registration

7009150

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

03/28/2023

Trademark type

Word

Nice classes

3

Filing date

07/30/2021

Registration date

03/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/28/2023

Last transaction

03/28/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

Seoul, KR

Examiner

YOUNG, THOMAS

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

APR Co., Ltd.

Representatives

Max Vern Amster, Rothstein & Ebenstein LLP

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Essential oils; Cosmetics; Incense; Cotton wool for cosmetic purposes; Cleansers for intimate personal hygiene purposesnon-medicated; Cosmetics for animals; Pre-moistened cosmetic tissues; Tissues impregnated with cosmetic lotions; Beauty balm creams; Cosmetic preparations for skin care; Skin creams; Beauty serums; Skin toners; Skin cleansers; Skin cleansing foams; Impregnated cleaning pads impregnated with cosmetics; Mask pack for cosmetic purposes; All of the foregoing comprised in substantial part of centella asiatica (CICA)

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/28/2023

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

02/22/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/22/2023

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/17/2023

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

01/17/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/08/2022

PUBO

PUBLISHED FOR OPPOSITION

11/08/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/20/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/20/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/20/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/30/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/29/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/29/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/26/2022

GNRT

NON-FINAL ACTION E-MAILED

08/26/2022

CNRT

NON-FINAL ACTION WRITTEN

08/26/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/25/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/25/2022

ALIE

ASSIGNED TO LIE

08/25/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/29/2022

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

04/28/2022

GPRA

PRIORITY ACTION E-MAILED

04/28/2022

CPRA

PRIORITY ACTION WRITTEN

04/28/2022

DOCK

ASSIGNED TO EXAMINER

04/27/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2021

NWAP

NEW APPLICATION ENTERED

08/03/2021

Continuous trademark protection

Get notified about every new filing that threatens MEDICUBE RED CENTELLA BALM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.